ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

Marker Research Plans Described; NCAB May Consider Asking For Special Study Section For Those Grants

March 11, 1983

NIH Revitalization Act Authorizes $3 Billion For NCI In FY97

July 5, 1996

NCI To Fund Only 30-35% Of Approved Grants Even With $815 Million Construction Slashed

August 20, 1976

Cancer Congress Scientific Program To Update Basic, Clinical Science

April 2, 1982

AACR Honors Nine Cancer Researchers, Clinicians.

March 31, 2000